These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19707956)

  • 1. Are masking abnormalities in schizophrenia specific to type-B masking?
    Skottun BC; Skoyles JR
    World J Biol Psychiatry; 2009; 10(4 Pt 3):798-808. PubMed ID: 19707956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are masking abnormalities in schizophrenia limited to backward masking?
    Skottun BC; Skoyles JR
    Int J Neurosci; 2009; 119(1):88-104. PubMed ID: 19116834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereopsis and magnocellular sensitivity in schizophrenia.
    Skottun BC; Skoyles JR
    World J Biol Psychiatry; 2009; 10(4 Pt 3):697-701. PubMed ID: 18609415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?
    Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z
    Psychol Med; 2005 Oct; 35(10):1445-55. PubMed ID: 16164768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vernier threshold in patients with schizophrenia and in their unaffected siblings.
    Kéri S; Kelemen O; Benedek G; Janka Z
    Neuropsychology; 2004 Jul; 18(3):537-42. PubMed ID: 15291731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual processing in schizophrenia: Structural equation modeling of visual masking performance.
    Rassovsky Y; Green MF; Nuechterlein KH; Breitmeyer BG; Mintz J
    Schizophr Res; 2005 Oct; 78(2-3):251-60. PubMed ID: 15975768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology.
    Butler PD; DeSanti LA; Maddox J; Harkavy-Friedman JM; Amador XF; Goetz RR; Javitt DC; Gorman JM
    Schizophr Res; 2003 Feb; 59(2-3):199-209. PubMed ID: 12414076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the 'magnocellular advantage' in visual impairments in neurodevelopmental and psychiatric disorders.
    Laycock R; Crewther SG; Crewther DP
    Neurosci Biobehav Rev; 2007; 31(3):363-76. PubMed ID: 17141311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A few remarks on attention and magnocellular deficits in schizophrenia.
    Skottun BC; Skoyles JR
    Neurosci Biobehav Rev; 2008; 32(1):118-22. PubMed ID: 17651801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual perception in medicated schizophrenic patients.
    Schwartz B; Winstead DK
    Am J Psychiatry; 1997 Apr; 154(4):585-7. PubMed ID: 9090363
    [No Abstract]   [Full Text] [Related]  

  • 11. The time course of visual backward masking deficits in schizophrenia.
    Skottun BC; Skoyles JR
    J Integr Neurosci; 2011 Mar; 10(1):33-45. PubMed ID: 21425481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia.
    Schechter I; Butler PD; Silipo G; Zemon V; Javitt DC
    Schizophr Res; 2003 Nov; 64(2-3):91-101. PubMed ID: 14613674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact figure-ground segmentation in schizophrenia.
    Herzog MH; Kopmann S; Brand A
    Psychiatry Res; 2004 Nov; 129(1):55-63. PubMed ID: 15572185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast sensitivity and magnocellular functioning in schizophrenia.
    Skottun BC; Skoyles JR
    Vision Res; 2007 Oct; 47(23):2923-33. PubMed ID: 17825350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment in visual and spatial perception in schizophrenia and delusional disorder.
    Hardoy MC; Carta MG; Catena M; Hardoy MJ; Cadeddu M; Dell'Osso L; Hugdahl K; Carpiniello B
    Psychiatry Res; 2004 Jun; 127(1-2):163-6. PubMed ID: 15261715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits.
    Rassovsky Y; Green MF; Nuechterlein KH; Breitmeyer B; Mintz J
    Schizophr Res; 2004 Dec; 71(2-3):485-92. PubMed ID: 15474919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoneglect in schizophrenia: a line bisection study with cueing.
    Michel C; Cavezian C; d'Amato T; Dalery J; Rode G; Saoud M; Rossetti Y
    Cogn Neuropsychiatry; 2007 May; 12(3):222-34. PubMed ID: 17453903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collinear contextual suppression in schizophrenic patients.
    Schütze C; Bongard I; Marbach S; Brand A; Herzog MH
    Psychiatry Res; 2007 Apr; 150(3):237-43. PubMed ID: 17321597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional brain activity associated with visual backward masking.
    Green MF; Glahn D; Engel SA; Nuechterlein KH; Sabb F; Strojwas M; Cohen MS
    J Cogn Neurosci; 2005 Jan; 17(1):13-23. PubMed ID: 15701236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Backward and forward visual masking in schizophrenia and its relation to global motion and global form perception.
    Brittain PJ; Surguladze S; McKendrick AM; Ffytche DH
    Schizophr Res; 2010 Dec; 124(1-3):134-41. PubMed ID: 20685082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.